日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth

白血病干细胞激活谱系异常信号通路以促进自身生长

Sophie G Kellaway ,Sandeep Potluri ,Peter Keane ,Helen J Blair ,Luke Ames ,Alice Worker ,Paulynn S Chin ,Anetta Ptasinska ,Polina K Derevyanko ,Assunta Adamo ,Daniel J L Coleman ,Naeem Khan ,Salam A Assi ,Anja Krippner-Heidenreich ,Manoj Raghavan ,Peter N Cockerill ,Olaf Heidenreich ,Constanze Bonifer

Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1

RAS的药理学抑制可通过AP-1和RUNX1克服FLT3-ITD+ AML中的FLT3抑制剂耐药性

Daniel J L Coleman ,Peter Keane ,Paulynn S Chin ,Luke Ames ,Sophie Kellaway ,Helen Blair ,Naeem Khan ,James Griffin ,Elizabeth Holmes ,Alexander Maytum ,Sandeep Potluri ,Lara Strate ,Kinga Koscielniak ,Manoj Raghavan ,John Bushweller ,Olaf Heidenreich ,Terry Rabbitts ,Peter N Cockerill ,Constanze Bonifer

Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia

CEBPA双突变急性髓系白血病基因调控网络的鉴定与探究

Assunta Adamo #, Paulynn Chin #, Peter Keane, Salam A Assi, Sandeep Potluri, Sophie G Kellaway, Daniel Coleman, Luke Ames, Anetta Ptasinska, H Ruud Delwel, Peter N Cockerill, Constanze Bonifer

Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth

基因调控网络分析预测了FLT3-ITD+ AML生长所需的协同转录因子调控子。

Daniel J L Coleman,Peter Keane,Rosario Luque-Martin,Paulynn S Chin,Helen Blair,Luke Ames,Sophie G Kellaway,James Griffin,Elizabeth Holmes,Sandeep Potluri,Salam A Assi,John Bushweller,Olaf Heidenreich,Peter N Cockerill,Constanze Bonifer

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction

t(8;21) AML 中 RUNX1-ETO 的缺失导致 C/EBPα 和 AP-1 介导的增强子-启动子相互作用改变

Anetta Ptasinska ,Anna Pickin ,Salam A Assi ,Paulynn Suyin Chin ,Luke Ames ,Roberto Avellino ,Stefan Gröschel ,Ruud Delwel ,Peter N Cockerill ,Cameron S Osborne ,Constanze Bonifer